Key terms
About SLP
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SLP news
Apr 16
5:48am ET
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
Apr 04
8:38am ET
Simulations Plus announces U.S. FDA renewed license to DILIsym platform
Apr 03
6:56pm ET
Simulations Plus backs FY24 EPS view 66c-68c, consensus 66c
Apr 03
6:55pm ET
Simulations Plus reports Q2 EPS 20c, consensus 19c
Apr 03
4:23pm ET
Simulations Plus Q2 Financial Performance and Outlook Warning
Apr 03
7:05am ET
Options Volatility and Implied Earnings Moves Today, April 03, 2024
Apr 01
8:36am ET
Craig-Hallum Remains a Buy on Simulations Plus (SLP)
Apr 01
7:00am ET
Options Volatility and Implied Earnings Moves This Week, April 01 – April 05, 2024
Mar 28
9:20am ET
Analysts Offer Insights on Healthcare Companies: PAVmed (PAVM) and Simulations Plus (SLP)
Mar 05
9:11am ET
FDA awards Simulations Plus a grant through proposal with University of Bath
Feb 28
5:55am ET
Simulations Plus management to meet with Oppenheimer
Feb 27
4:55am ET
Simulations Plus management to meet with Oppenheimer
Feb 20
8:37am ET
Simulations Plus management to meet with Oppenheimer
Feb 15
9:05am ET
Simulations Plus extends pact with Translational Toxicology Division at NIEHS
Feb 13
9:32am ET
Simulations Plus to Present at Oppenheimer Conference
Feb 12
4:13pm ET
Simulations Plus Shareholders Elect Board, Boost Growth Plan
No recent press releases are available for SLP
SLP Financials
Key terms
Ad Feedback
SLP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SLP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range